TY  - JOUR 
AU  - Zugazagoitia, J
AU  - Ramos, I
AU  - Trigo, J M
AU  - Palka, M
AU  - Gomez-Rueda, A
AU  - Jantus-Lewintre, E
AU  - Camps, C
AU  - Isla, D
AU  - Iranzo, P
AU  - Ponce-Aix, S
AU  - García Campelo, María del Rosario
AU  - Provencio, M
AU  - Franco, F
AU  - Bernabe, R
AU  - Juan-Vidal, O
AU  - Felip, E
AU  - de Castro, J
AU  - Sanchez-Torres, J M
AU  - Faul, I
AU  - Lanman, R B
AU  - Garrido, P
AU  - Paz-Ares, L
PY  - 2019
SN  - 0923-7534
UR  - http://hdl.handle.net/20.500.11940/15952
AB  - BACKGROUND: Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We have analyzed the clinical utility of next-generation sequencing (NGS) of cell-free...
LA  - eng
KW  - Proto-Oncogene Proteins
KW  - Adult
KW  - Genome
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Follow-Up Studies
KW  - Genomics
KW  - Survival Rate
KW  - DNA
KW  - Mutation
KW  - Lung Neoplasms
KW  - Humans
KW  - Prospective Studies
KW  - High-Throughput Nucleotide Sequencing
KW  - Aged
KW  - Prognosis
TI  - Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
DO  - 10.1093/annonc/mdy512
T2  - ANNALS OF ONCOLOGY
KW  - CHUAC
VL  - 30
ER  -